Photo by Kanchanara on Unsplash
 

Bayer AG bears the ticker symbol BAYRY. This is my first report on Bayer AG for my Viking portfolio.  However, I have selected it as a candidate for one of my previous seven Dog of the Week portfolios.

Bayer is a German healthcare and agriculture conglomerate.

Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins.

The firm has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.

It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers.

Bayer AG was founded in 1863 and is headquartered in Leverkusen, Germany.

Three key data points gauge Bayer AG:

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether any company has made, is making, and will make money.
 

BAYRY Price

Bayer’s price per share was $13.69 at Wednesday’s market close. However, in the past year, Bayer’s share price fell by $0.56, or about 3.9%.

If Bayer’s stock trades in the range of $9.00 to $18.00 this next year, its recent $13.69 share price might reach $17.00 by next year. My upside increase estimate of $3.31 is $3.82 below the median of annual price targets for Bayer calculated by two analysts.
 

BAYRY Dividends

Bauer’s most recently declared annual dividend of $0.5258 per share casts a yield of 3.84%.
 

BAYRY Returns

Adding the $0.5258 annual BAYRY dividend to my one-year price upside estimate of $3.31 shows a $3.84 potential gross gain per share.

At Tuesday’s $13.69 closing price, a little over $1000 would buy 73 shares.

A $10 broker fee (if charged), paid half at purchase and a half at the sale, might cost us about $0.14 per share.

Subtracting that maybe $0.14 brokerage cost from my estimated $3.84 gross gain per share results in a net gain of $3.70 X 73 shares = $270.10 for a 27% net gain including a 3.84% annual dividend yield.

In a year our $1K investment in shares of Bayer would generate $38.40 in cash dividends. Of course, a single share of BAYRY stock at Wednesday's $13.69 price is nearly 2.5 times less than the annual dividend income from our $1000.00 investment.

So, by my dogcatcher ideal, this may be a prime time to buy Bayer AG shares based on their dividends for the coming year 2022-23. The current dividend from $1K invested is 2.45 times greater than Bayer’s single share price. Consider yourself alerted.

All of the estimates above are speculation based on the past history of Bayer AG. Only time and money invested in this stock will determine its market value.

More By This Author:

Daily Stock Analysis: Sanofi - November 2022 Snapshot
Daily Stock Analysis: GSK plc
Current Report: HP Inc.